Current Paradigms in Cardiovascular Care of the Cancer Patient / SURVIVOR

Biennial, multidisciplinary, interprofessional educational symposium aimed at addressing the latest advances and clinical strategies in managing cardiovascular risks associated with cancer therapies.

Friday, October 3, 2025 | 7:30 AM – 3:30 PM | Waldorf Astoria Chicago

The Heart of Cardio-Oncology Care

  • A middle-aged man with glasses, bald head, and a goatee, smiling, wearing a white lab coat and purple tie

    KEYNOTE SPEAKER

    Northwestern Memorial HealthCare

    Dr. Clyde Yancy, Vice Dean at Northwestern, is a nationally recognized cardiologist with 500+ publications and deep expertise in heart failure. A leader in advancing equity and cardiovascular care, his work spans research, mentorship, and public health.

  • Portrait of a woman with shoulder-length dreadlocks, wearing a red top, smiling, against a gray background.

    CHAIR & COURSE DIRECTOR

    Rush University Medical Center

    Dr. Tochukwu Okwuosa is a leader in cardio-oncology, known for building innovative programs that improve care for patients with cancer and heart disease. She’s also a dedicated educator shaping future providers through national and regional initiatives.

  • Portrait of a woman smiling, wearing a red blazer and earrings, with shoulder-length dark hair against a white background.

    Supporting Faculty

    Rush University Medical Center

    Dr. Annabelle S. Volgman, founding director of the Rush Heart Center for Women, is a champion for women’s heart health. Her work blends research, clinical care, and advocacy to elevate awareness and treatment of cardiovascular disease in women.

This accredited one-day symposium will feature didactic lectures, panel discussions, and poster presentations, all led by distinguished experts.

  • Who

    Physicians: Cardiologists, oncologists, internists, and hospitalists

    Advanced Practice Providers: Nurse practitioners and physician assistants

    Pharmacists and Nurses

    Medical trainees and fellows

    Professionals interested in improving cancer survivorship and reducing treatment-related cardiac complications

    Group of five medical professionals, including doctors and nurses, sitting and standing around a conference table in a bright office, smiling for the camera.
  • What

    A full-day, single-track program of didactic lectures, expert panels, and poster presentations

    Ample networking opportunities with clinicians, researchers, and industry leaders

    Up to 5.25 hours of CME/CE credit for physicians, nurses, and pharmacists

    Hosted in the elegant Waldorf Astoria Chicago, offering a professional and focused setting for learning and collaboration

    A female doctor using a stethoscope to examine an elderly male patient with gray hair and beard in a doctor's office.
  • Why

    This biennial CME-accredited conference explores the evolving intersection of cancer therapies and cardiovascular care. Led by experts from Rush University Medical Center, it brings providers together for an immersive, cross-disciplinary experience. As treatments like chemo, radiation, and CAR-T evolve, so do their cardiac risks. This event equips clinicians to prevent, detect, and manage cancer therapy–related cardiac dysfunction (CTRCD) across the care continuum.

    Group of healthcare professionals, including an older female doctor with glasses, discussing an X-ray in a bright medical setting.

Where

Waldorf Astoria

11 E. Walton Street, Chicago IL

Friday, October 3, 2025
7:30 AM – 3:30 PM

Faculty & Expert Speakers

Driving the Future of Cardio-Oncology

Cardio-Oncology Topic Overview

  • Cardiotoxicity of chemotherapy, radiation, and targeted therapies

  • Immune checkpoint inhibitors and associated cardiovascular side effects

  • Cardiovascular implications of CAR-T cell therapy and stem cell transplants

  • Practical strategies for mitigating cardiovascular risks

  • Artificial Intelligence in Cardio-Oncology

  • Cardiovascular considerations in cancer survivorship

  • Novel treatments: SGLT2 inhibitors, GLP-1 agonists, NOACs, Others

  • Advanced cardiovascular imaging for early detection and management: Cardiac MRI, PET, CT, 3D Echo

Be Part of the Conversation Shaping the Future of
Cardio-Oncology